New York, USA, 31st August 2026, FinanceWire … Read More
Medical
After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)
WSW, NY, 25th August 2026, FinanceWire … Read More
New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq: MDWD)
WSW, NY, 25th August 2026, FinanceWire … Read More
Immunotherapy’s Biggest Blind Spot Is a $7 Billion Market. Silexion May Have a Way In (NASDAQ: SLXN)
WSW, NY, 10th August 2026, FinanceWire … Read More
PolyPid’s Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule (NASDAQ: PYPD)
WSW, NY, 31st July 2026, FinanceWire … Read More
Why the World’s Leading Healthcare Funds All Wanted a Piece of Entera Bio (NASDAQ: ENTX)
WSW, NY, 30th July 2026, FinanceWire … Read More
Alpha Tau’s Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda’s Historical Benchmark
WSW, NY, 29th July 2026, FinanceWire … Read More
Silexion Activates First Site in Phase 2/3 Trial Targeting KRAS-Driven Pancreatic Cancer (NASDAQ: SLXN)
WSW, NY, 29th July 2026, FinanceWire … Read More
Vita Hydrokultur Opens £1.5m Series A Round to Scale Plant-Grown Skincare Ingredients
London, United Kingdom, 27th July 2026, FinanceWire … Read More
InkWell Health Surpasses Halfway Mark in $2.2M Seed Round as Data-Driven Recovery Care Gains Investor Momentum
Troy,Michigan, United States, 24th July 2026, FinanceWire … Read More